# Hangzhou DAC Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-dac-biotech-co

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.dacbiotech.com
- Total disclosed funding: $162M
- Latest round: Series C (May 10, 2021)
- Investors on record: 14

## About

Based in Hangzhou, China and established in 2012, Hangzhou DAC Biotech Co., Ltd is a biotechnology company that engages in the research and development of conjugate of monoclonal antibody and small molecular cytotoxic drug. The company’s core technical team includes 5 overseas returnees, 36 domestically graduated doctors and masters, and more than 40 bachelor’s degree professional and technical personnel.

The company mainly develops antibody-drug conjugates, including tubulin inhibitors, DNA groove inhibitors, DNA alkylation and RNA polymerase inhibitors. It targets tumor cells through antibodies, and releases cytotoxic drugs through chemical or enzymatic action at the tumor to achieve precise killing of tumor cells.

## Funding rounds

- Series C, May 10, 2021, $155M — CPE Funds Management, CITIC Securities, TigerYeah Capital, K.WAH Group, GL Ventures, CDG Capital
- Series B, Sep 18, 2019 — Coastal Capital, Shanghai Junshi Biosciences Co., Ltd., Jinyi Investment
- Series B, Jan 12, 2018 — Zhejiang Gcredit Investment Management
- Angel, Nov 27, 2015, $6.3M — Betta Pharmaceuticals, ZJKF Capital Management, Addor Capital, Zheke Investment Management

## Investors

- Betta Pharmaceuticals — Angel
- ZJKF Capital Management (https://capitalatlas.ai/funds/zjkf-capital-management) — Angel
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Angel
- Zheke Investment Management (https://capitalatlas.ai/funds/zheke-investment-management) — Angel
- Zhejiang Gcredit Investment Management (https://capitalatlas.ai/funds/zhejiang-gcredit-investment-management) — Series B
- Coastal Capital (https://capitalatlas.ai/funds/coastal-capital) — Series B
- Shanghai Junshi Biosciences Co., Ltd. — Series B
- Jinyi Investment — Series B
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series C
- CITIC Securities — Series C
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Series C
- K.WAH Group — Series C
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series C
- CDG Capital (https://capitalatlas.ai/funds/cdg-capital) — Series C